News from Biogen Inc.
Category: Industry News
BNA Journal Indexing
News from the British Neuroscience Association
Fampyra® (fampridine) becomes first treatment funded by NHS Scotland to improve walking difficulties in adult patients with all types of multiple sclerosis (MS)
News from Biogen
First super-resolution image of tiny brain receptor could give scientists a better understanding of Parkinson’s and Alzheimer’s
Academic news from University of Birmingham
Outstanding! The Children’s Trust celebrates top CQC & Ofsted ratings whilst facing its biggest challenge in its history
News and fundraising appeal from The Children’s Trust
Healthcare professionals needed for free virtual consultation service
New service to ease short term strain on the NHS – you can volunteer now
Licence update for BOTOX® increases involvement of MDT
News of BOTOX® licence update
Fremanezumab – first anti-CGRP preventive therapy approved by NICE
Positive Recommendation by NICE for first anti-CGRP migraine therapy: AJOVY®▼ (fremanezumab)
Data from Phase III Trial “SPI2” for Treatment of Progressive MS
News from MedDay Pharma
